---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-098047"
form_type: "8-K"
ticker: "VYGR"
cik: "0001640266"
company_name: "Voyager Therapeutics, Inc."
filed_at: "2022-09-07T23:59:59+00:00"
generated_at: "2026-06-23T14:15:34.153217+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Voyager Therapeutics appoints new CFO, CSO, and SVP of Corporate Affairs

## Summary
- Peter Pfreundschuh named CFO effective Sept 19, 2022; base salary $455K, target bonus 40%, 200K option + 125K RSU.
- Todd Carter promoted to CSO effective Sept 19, 2022; base salary $410K, target bonus 40%, 165K option.
- Trista Morrison appointed SVP of Corporate Affairs and Chief of Staff to CEO effective Sept 19, 2022.
- Julie Burek remains VP of Finance; Pfreundschuh assumes principal financial and accounting officer roles.
- Equity grants for Pfreundschuh are inducement awards under Nasdaq Listing Rule 5635(c)(4).

## SEC filing metadata
- accession: 0001104659-22-098047
- form_type: 8-K
- ticker: VYGR
- cik: 0001640266
- company_name: Voyager Therapeutics, Inc.
- filed_at: 2022-09-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1640266/000110465922098047/0001104659-22-098047-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1640266/000110465922098047/tm2225311d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-098047
- JSON: https://secwatch.observer/filing/0001104659-22-098047.json
- Plain text: https://secwatch.observer/filing/0001104659-22-098047.txt

## Key facts
- Executive change
  Peter P. Pfreundschuh was appointed as Chief Financial Officer at Voyager Therapeutics, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: pursuant to which Mr. Pfreundschuh agreed to serve as the Chief Financial Officer of the Company, with the first date of employment to commence on September 19, 2022
  evidence_url: https://www.sec.gov/Archives/edgar/data/1640266/000110465922098047/0001104659-22-098047-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.